Stock listing

PBS0 Stock Price, News, Filings & Events — Precision Biosciences, Inc.

Selected listing: PBS0 · MUN · EUR · DE

This page tracks Precision Biosciences, Inc.'s PBS0:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBS0:MUN. PBS0:MUN is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.

PBS0:MUNEURDEUpdated September 11, 2026
Precision Biosciences, Inc. logo
Ticker
PBS0:MUN
Asset type
Stock
Market cap
$197.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
MUN
Currency
EUR

Precision Biosciences, Inc. PBS0:MUN stock context

This page tracks Precision Biosciences, Inc.'s PBS0:MUN listing on MUN in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PBS0:MUN. PBS0:MUN is the stock-level entry point for investors researching Precision Biosciences, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precision Biosciences, Inc. is a publicly traded company in the American market, with a market capitalization of approximately $188 million. The company focuses on developing innovative gene editing technologies and therapies. As a leader in its field, Precision Biosciences aims to advance the treatment of various diseases through its proprietary platform.

Latest news from Precision Biosciences, Inc.

All Precision Biosciences, Inc. news →

Research Precision Biosciences, Inc.

Alternate listings